| Today, Fri, Dec 4, 2009 | | • | Biggest Cash Positions of the S&P
at CNBC (Fri 8:13am)
| | • | Why Biologics Remain Expensive
at Forbes.com (Fri 6:00am)
| | Thu, Dec 3, 2009 | | • | Jazz Pharmaceuticals appoints ARCA exec as CFO
AP (Thu 2:45pm)
| | • | Should Amgen Buy Human Genome Sciences?
at Forbes.com (Thu 2:06pm)
| | • | Jazz Pharmaceuticals names CFO
at bizjournals.com (Thu 2:05pm)
| | • | New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
PR Newswire (Thu 1:04pm)
| | • | No Holiday For Biopharma P & A
at CNBC (Thu 11:54am)
| | Wed, Dec 2, 2009 | | • | Tired of Waiting, Teva Advances
at Motley Fool (Wed, Dec 2)
| | • | Buy This Investment If You Want to Lose Money
at Motley Fool (Wed, Dec 2)
| | • | [$$] Teva Carries Israel and Biotech ETFs
at RealMoney by TheStreet.com (Wed, Dec 2)
| | • | Another View: Innovation Can Unlock Job Growth
at The New York Times (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | • | UPDATE - Teva seeks FDA nod for biosimilar of Amgen drug
at Reuters (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | • | Amgen Highlights Data to be Presented at ASH
PR Newswire (Mon, Nov 30)
| | • | The Comeback Kids: The Interviews
at SmartMoney.com (Mon, Nov 30)
| | Sun, Nov 29, 2009 | | • | Soft-talking revolutionary
at FT.com (Sun, Nov 29)
| | • | 8 HealthCare Stocks With 3%+ Dividends
at Seeking Alpha (Sun, Nov 29)
| | Sat, Nov 28, 2009 | | • | Less Toxic Monoclonal Antibodies And Increased Patent Protection For Biologics Creates Multiple Positive Investment Scenarios In Biotechnology Sector
Wall Street Transcript (Sat, Nov 28)
| | Fri, Nov 27, 2009 | | • | This Big Winner Has Hit Its Prime
at Motley Fool (Fri, Nov 27)
| | Wed, Nov 25, 2009 | | • | Dream Stocks for Biotech Investors
at Motley Fool (Wed, Nov 25)
| | • | Novartis Didn't Know JAK, Until Now
at Motley Fool (Wed, Nov 25)
|
Add AMGN News to My Yahoo!:
 
| |
|
0.22% Nasdaq 
Headlines
